Flex Pharma, Inc. 4
4 · Flex Pharma, Inc. · Filed May 30, 2017
Insider Transaction Report
Form 4
McVicar William K.
President, R&D
Transactions
- Award
Stock Option (right to buy)
2017-05-26+200,000→ 200,000 totalExercise: $3.37Exp: 2027-05-26→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the total shares underlying this option vest on April 5, 2018 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.